23 February 2026, Morges, Switzerland: Kainjoo confirms that its media arm, TreatMyBrand.com, is officially recognised as a member of the press. The accreditation has been issued by GNS Press, operator of presseausweis.com. TreatMyBrand.com’s published Editorial Mission and Guidelines define its operating standards: editorial independence, accuracy and verification, corrections, transparency, and a strict separation between editorial and commercial activity.
- TreatMyBrand.com recognised as press member by GNS Press (presseausweis.com)
- Haider Alleg appointed Editor-in-Chief, accountable for editorial standards, sourcing, and corrections
- Editorial mission: regulated industries and technology, with a cross-border Switzerland–EU–US lens
TreatMyBrand.com delivers field coverage through event reporting and on-the-record interviews with leaders in the space, including TechEx, Reuters Pharma, and Next Pharma. TreatMyBrand.com curates and syndicates news from relevant outlets worldwide, with clear attribution and cross-border context that supports decision-grade understanding. TreatMyBrand.com also serves as a growing press release and announcements platform, giving brands a disciplined channel to reach the market with news. A community inside TreatMyBrand.com supports discovery, dialogue, and distribution.
Regulated organisations face execution risk when product, data, and go-to-market systems cross jurisdictions. TreatMyBrand.com documents what changes, what transfers, and what breaks, connecting governance, technology, and real-world execution across Switzerland, the EU, and the US.
“Regulated industries demand clarity across borders,” said Haider Alleg, Editor-in-Chief. “TreatMyBrand.com publishes coverage that connects governance, technology, and real-world execution, and it gives brands a disciplined channel to release market news.”
About TreatMyBrand.com
TreatMyBrand.com is the media arm of Kainjoo. It publishes reporting, interviews, and syndicated coverage on regulated industries and technology, with an emphasis on cross-border clarity and editorial accountability.
